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Letters to the Editorof leaflet thickening might best repre-
sent rheumatic disease, which was
seen in 4 patients. Another 27 patients
had no leaflet pathologic features
(only annular dilatation with or
without tethering), and it could be
defined as ‘‘idiopathic’’ or ‘‘func-
tional.’’ As such, specifying the
etiology in every case would have
been very difficult or perhaps impos-
sible in some cases. Therefore, we
believe that describing the pathologic
features (leaflet abnormality, annular
dilatation, tethering), rather than
specifying the etiology, was a more
reasonable method.
The PAP can be estimated by the
levels of the TR pressure gradient,
which were 27.5  9.0 mm Hg
and 22.6  7.7 mm Hg for those
undergoing tricuspid valve repair
and replacement, respectively, as
described in our Table 2.1 Generally,
systolic PAP has been estimated by
this value, with 5 mm Hg added for
the estimated right atrial pressure.2
Given that patients with severe TR
tend to have a higher right atrial
pressure, the addition of 15 to
20 mm Hg might be needed in some
cases. Nevertheless, the estimated
PAP was still within normal range,
as expected, because the patients did
not have any left-sided cardiac
lesions.
Finally, regarding the influence of
PAP on the long-term outcomes in
patients with severe TR, we have tried
to address this issue by analyzing
patients with severe TR of all
etiologies and the results now
available from a published study.3
In that study, 449 patients were
included. Of these patients, 60
(13.4%) had a history of left-sided
valve surgery and 359 (80.0%)
had undergone concomitant left-
sided valve surgery. On multivariate
analysis, survival was affected by
advanced heart failure symptoms,
comorbidities, end-organ dysfunction,
and laboratory abnormalities, but not
by the type of surgery, causes of TR,
or PAP level. It is well known thatThe Journalthe preoperative PAP level is
associated with late outcomes after
left-sided valve surgery; however,
we also know that the surgical
outcomes of primary isolated TR
(with normal PAP) have also been
poor, which has been more related
to right ventricular dysfunction.
Therefore, we have assumed that the
effects of ‘‘higher PAP’’ in patients
with secondary TR and ‘‘normal
PAP’’ in those with primary TR
have been counterbalanced in the
long-term outcomes. However, we
also believe this issue should be
addressed in additional studies with
more sophisticated designs.
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MEMBRANE OXYGENATION
RESUSCITATION IN ADULT
PATIENTS WITH REFRACTORY
SEPTIC SHOCK
To the Editor:
We read the interesting report by
Huang and colleagues,1 in which
they described their experience using
extracorporeal membrane oxygena-
tion (ECMO) for adults with refrac-
tory septic shock. The investigatorsof Thoracic and Cardiovascular Surgerconclude that ECMO should not
be regarded as a rescue modality
in patients with refractory septic
shock, as highlighted by impaired
hemodynamics and progression of
inflammation-mediated organ failure.
The findings of profound shock and
multiple organ dysfunction among
these patients supported by ECMO,
despite appropriate antibiotics and
high-dose inotropes, redirect our
concern about a profound inflamma-
tory response, which possibly affects
their pharmacokinetics. Recently,
Angus and Van der Poll2 inferred
that proinflammatory reactions lead
to collateral tissue damage in severe
sepsis, and impaired tissue oxygena-
tion plays a vital role in organ
dysfunction. Moreover, it is well
known that venoarterial ECMO pro-
vides oxygenation and hemodynamic
stability, although it does not filter
the uncontrolled, circulating, acute in-
flammatory mediators that worsen tis-
sue damage.
Currently, extracorporeal blood pu-
rification therapies have been pro-
posed to limit these circulating
inflammatory mediators,3 but they do
not yet seem to be used in mainstream
clinical practice because of their prac-
tical and theoretic limitations. In our
experience,4 a combination of extra-
corporeal life support and plasma pu-
rification by resin adsorption has
been shown to play an important role
in the removal of proinflammatory cy-
tokines in the early phase of septic
shock, thereby preventing further he-
modynamic deterioration and
reducing the risk of multiple organ
dysfunction. In this ex vivo study,
the extracorporeal blood flow through
the resin adsorption filter was set at a
flow rate of 300 mL/min to achieve
higher single-pass clearance and
quantities of acute inflammatory me-
diators. The improvements in hemo-
dynamics were reflected in a
decrease in the mean pulmonary ar-
tery and central venous pressure, and
a concurrent increase in systemic
vascular resistance was observed iny c Volume 147, Number 4 1441
Letters to the Editorthe study group with significant levels
of adsorption of the measured
cytokines. Further decrease in
interleukin-6 and tumor necrosis fac-
tor a levels were observed even after
stopping the adsorption process,
possibly as a result of the compensa-
tory antiinflammatory response
syndrome.5
Therefore, we can assume that early
resolution of hemodynamics might
significantly influence the survival
outcome. Thus, adjuvant plasma puri-
fication therapy during ECMO sup-
port should be considered to adsorb
unregulated quantities of acute in-
flammatory mediators. Nonetheless,
further large-scale studies are
necessary to establish whether a1442 The Journal of Thoracic andcombination of extracorporeal life
support and plasma purification by
resin adsorption may play an impor-
tant role in preventing further hemo-
dynamic deterioration and reducing
the risk of multiorgan failure in septic
shock.
We are grateful to Huang and col-
leagues1 for sharing their experience
and knowledge in this excellent study
and for giving an important insight
into such a controversial issue.
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